Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-136882
Filing Date
2022-05-02
Accepted
2022-05-02 16:40:13
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d766347ddefa14a.htm DEFA14A 11304
2 GRAPHIC g766347dsp004.jpg GRAPHIC 305236
3 GRAPHIC g766347dsp005.jpg GRAPHIC 243275
  Complete submission text file 0001193125-22-136882.txt   768458
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14956 | Film No.: 22882635
SIC: 2834 Pharmaceutical Preparations